Introduction Tranexamic acid (TXA) is a synthetic derivative of the amino acid lysine that inhibits fibrinolysis by blocking lysine-binding sites on plasminogen, which contribute to reduced bleeding, ...

The primary outcome for the meta-analysis was absence of death from bleeding. ‘Treatment delay’ was the exposure of interest and defined as the interval between bleeding onset and start of tranexamic ...

Hyperpigmentation is a skin condition that can result in uneven skin tone. Stylist looks into what makes tranexamic acid an effective ingredient to make skin appear brighter and more even.

Objective To describe the use of tranexamic acid (TXA) in trauma care in England and Wales since the Clinical Randomization of an Antifibrinolytic in Significant Hemorrhage (CRASH-2) trial results ...

Objectives To investigate the efficacy and safety of subcutaneously (SC) administered tranexamic acid. Methods A retrospective chart review of the use of SC tranexamic acid in a single palliative care ...